Loading asset research
+9.12%
Today
Loading 1D prices…
Company profile
Kira Pharmaceuticals develops complement-targeted therapies to treat immune-mediated diseases. The company was founded in 2017 and is based in George Town, Cayman Islands.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
REDWOOD CITY, CA, United States
Employees
22
Fiscal year end
1231
CIK
1788028
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BCDABioCardia Inc. Common Stock | $18M | $0.00 | — | -$1.23 | -10.80% | Buy |
| TCRXTScan Therapeutics Inc. Common Stock | $22.8M | $10.3M | -1256.81% | -$1.00 | +0.91% | Hold |
| DYAIDyadic International Inc. Common Stock | $16.2M | $3.1M | -238.31% | -$0.23 | +5.00% | Buy |
| PASGPassage Bio Inc. Common Stock | $15.6M | $0.00 | — | -$14.35 | +3.70% | Hold |
| CVMCel-Sci Corporation Common Stock | $26M | $0.00 | — | -$1.76 | +0.68% | Unrated |